Skip to main content
CDC Website

Health Planners

MMWR: Vital Signs: HIV Testing and Diagnosis Among Adults --- United States, 2001--2009

This report discusses a study on HIV testing and diagnosis among adults in the United States, 2001-2009. CDC used 2001-2009 data from the National Health Interview Survey to calculate the percentage of persons aged 18-64 years who reported ever being tested for HIV in the United States. Also, data from the National HIV surveillance system were used to estimate numbers, percentages, and rates of HIV diagnoses; AIDS diagnoses; and late diagnoses of HIV infection for persons diagnosed with HIV infection during 2001-2008 and reported to CDC through June 2009.

Strategic Realignment of Funding to Support Priorities in Sexual Health and STD Disparities Among Racial and Ethnic Minorities

This report provides a record of the proceedings of the Legacy Funding Realignment Consultation held on July 8, 2010, in Atlanta, Georgia. It includes notes on the opening session, an overview of the consultation, an overview of the Division of STD Prevention Priorities, an overview of challenges and opportunities in STD disparities in the United States, and an overview of the CDC National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention’s (NCHHSTP) Public Health Ethics Activities.

MMWR: Estimated Lifetime Risk for Diagnosis of HIV Infection Among Hispanics/Latinos — 37 States and Puerto Rico, 2007

This report calculates the estimated lifetime risk (ELR) and age-conditional risk for diagnosis of HIV infection among Hispanics/Latinos in 37 states and Puerto Rico. The CDC analyzed HIV surveillance data, vital statistics data on general and HIV-specific mortality, and US Census data from 2007. Results indicate that an estimated 1.92 percent (one in 52) Hispanics/Latinos would be diagnosed with HIV during their lifetimes, compared with an ELR of .59 percent (one in 170) for whites, and 4.65 percent (one in 22) for blacks/African Americans.

HIV/AIDS Statistics and Reports: Annual Report 2010

This internet file of the 2010 annual report from the Arizona Department of Health Services contains sections in PDF and Power Point formats. Arizona county health information is also provided.

Estimates of New HIV Infections in the United States, 2006 - 2009

This information sheet presents new estimates of the annual number of new HIV infections (HIV incidence) in the United States released by CDC in August 2011. The estimates, for 2006 through 2009, are the first multi-year estimates using CDC’s national HIV incidence surveillance methodology, which is based on direct measurement of new HIV infections using a laboratory test (the BED HIV-1 Capture Enzyme Immunoassay) that can classify new diagnoses as either recent or long-standing HIV infections.

Expanded Testing Program: Overview

This information sheet discusses CDC’s expanded testing program for increasing the number of persons who are aware of their HIV status in order to prevent HIV infections. CDC established the expanded Testing Initiative, under which three programs have been launched: PS07-768, PS10-10138, and PS12-201. The information sheet explains the goals of these programs, accomplishments, and opportunities for moving forward.

Hepatitis & HRSA's Ryan White HIV/AIDS Program

This information sheet lists documents pertaining to hepatitis by the HHS Ryan White HIV/AIDS program. The list includes HCV documents and resources already published and under development, special projects of national significance models of care, Ryan White legislative references to hepatitis, and the national hepatitis action plan.

Volume and Type of Laboratory Testing Methods for Sexually Transmitted Diseases in Public Health Laboratories 2007: Summary Report

This report provides a summary of responses from a web-based survey of public health laboratories on volume and type of testing for STDs in the United States in 2007. The survey was conducted in 2008. Responses were received from 61.4 percent (94 of 153) participants. In 2007, 3,290,390 chlamydia tests and 3,157,827 gonorrhea tests were performed in the surveyed laboratories; 89.7 percent of chlamydia tests and 84.4 percent of gonorrhea tests were nucleic acid amplification tests. Over 90 percent of responders reported syphilis testing.

MMWR: Discordant Results From Reverse Sequence Syphilis Screening - Five Laboratories, United States, 2006-2010

This report describes tests of an analysis of data from five laboratories that used reverse sequence screening during 2006-2010 to identify persons with possible untreated syphilis. Three sites served patient populations with low prevalence of syphilis, and two sites served patient population with high prevalence. The results indicated that among sera reactive on initial screening with an automatable treponemal enzyme and chemiluminescence immunoassays (EIA/CIA), 56.7 percent had a nonreactive rapid plasma regain (RPR) test.